SCHEMBL7790037

SCHEMBL7790037

CCCC(=S)C(CCS)CCCCC(=O)OC(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.32
EPHX2 P34913 1/20 0.32
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
ATM Q13315 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
LMNA P02545 2/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
FOLH1 Q04609 1/20 0.30
PRSS1 P07477 1/20 0.30
CTSG P08311 1/20 0.30
CTRB1 P17538 1/20 0.30
CMA1 P23946 1/20 0.30
CPB2 Q96IY4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7792778 0.86 CTSK (0.32) CTSKEPHX2CYP3A4TSHRATM
SCHEMBL7784255 0.86 L3MBTL1 (0.40) EPHX2CYP3A4TSHRATMTDP1
SCHEMBL7790029 0.84 CYP1A2 (0.40) CYP3A4TSHRATMTDP1LMNA
SCHEMBL7793684 0.83 LMNA (0.51) CYP3A4TSHRLMNAMEN1GAA
SCHEMBL7793676 0.82 DGKA (0.45) CYP3A4TSHRATMTDP1LMNA
SCHEMBL7784240 0.81 FOLH1 (0.45) TSHRTDP1MEN1KMT2AFOLH1
SCHEMBL8104544 0.79 EPHX2 (0.35) CTSKEPHX2HDAC4HDAC1MEN1
SCHEMBL7794212 0.76 CTSK (0.32) CTSKEPHX2CYP3A4TSHRATM
SCHEMBL7790033 0.74 FOLH1 (0.34) CTSKEPHX2HDAC4HDAC1MEN1
SCHEMBL6740235 0.73 FOLH1 (0.44) EPHX2TSHRTDP1HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0947503-B1 6,8-Dimethylmercaptooctanoic acid derivatives substituted on 6-S and/or 8-S by the 3-methylthiopropanoyl radical and pharmaceutical compositions for the treatment of cancerous tumours GALDERMA RES & DEV (FR) 2001-11-21 EP claimed
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US claimed
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US disclosed